Genmab A/s

(OTC) GNMSF

Current Price$265.00

Market Cap$15.83B

Since IPO (2004)+1,539%

5 Year-29%

1 Year+29%

1 Month+0%

Genmab A/s Financials at a Glance

Market Cap

$15.83B

Revenue (TTM)

$13.01B

Net Income (TTM)

$3.89B

EPS (TTM)

$15.43

P/E Ratio

17.04

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$265.00

Volume

Open

$265.00

Price

$265.00

Volume

Open

$265.00

Previous Close

$265.00

Daily Range

$265.00 - $265.00

52-Week Range

$188.80 - $352.00

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$265.00

Volume

Open

$265.00

Previous Close

$265.00

Daily Range

$265.00 - $265.00

52-Week Range

$188.80 - $352.00

GNMSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genmab A/s

Industry

Biotechnology

Sector

Health Care

Employees

3,029

CEO

Jan G. J. van de Winkel, PhD

Website

www.genmab.com

Headquarters

Copenhagen, 1560, DK

GNMSF Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

37%

Net Income Margin

21%

Return on Equity

18%

Return on Capital

59%

Return on Assets

30%

Earnings Yield

5.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.83B

Shares Outstanding

59.73M

Volume

Avg. Volume

386.825

Financials (TTM)

Gross Profit

$3.53B

Operating Income

$1.29B

EBITDA

$1.37B

Operating Cash Flow

$1.23B

Capital Expenditure

$38.30M

Free Cash Flow

$1.19B

Cash & ST Invst.

$1.71B

Total Debt

$5.54B

Genmab A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.06B

-83.5%

Gross Profit

$981.37M

-83.9%

Gross Margin

92.34%

N/A

Market Cap

$15.83B

N/A

Market Cap/Employee

$6.00M

N/A

Employees

2,638

N/A

Net Income

$31.14M

-99.2%

EBITDA

$244.09M

-89.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.83B

-119.1%

Accounts Receivable

$1.15B

-82.9%

Inventory

$17.92M

-71.1%

Long Term Debt

$5.25B

+459.8%

Short Term Debt

$289.71M

+214.9%

Return on Assets

30.26%

N/A

Return on Invested Capital

59.45%

N/A

Free Cash Flow

$289.23M

-89.0%

Operating Cash Flow

$302.44M

-88.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WXXWYWuXi Biologics (Cayman) Inc.

WXXWYWuXi Biologics (Cayman) Inc.$8.55+1.03%

GIKLYGrifols, S.A.

GIKLYGrifols, S.A.$5.18+0.00%

SBMFFSino Biopharmaceutical Limited

SBMFFSino Biopharmaceutical Limited$0.76-0.00%

SBHMYSino Biopharmaceutical Limited

SBHMYSino Biopharmaceutical Limited$14.29+0.00%

IVBXFInnovent Biologics, Inc.

IVBXFInnovent Biologics, Inc.$11.25+0.00%

WXIBFWuXi Biologics (Cayman) Inc.

WXIBFWuXi Biologics (Cayman) Inc.$4.70+0.00%

ORINYOrion Oyj

ORINYOrion Oyj$37.99+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

FFord Motor Company

FFord Motor Company$11.88-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.84+0.01%

Questions About GNMSF

What is the current price of Genmab A/s?

Genmab A/s is trading at $265.00 per share.

What is the 52-week range for Genmab A/s?

Over the past 52 weeks, Genmab A/s has traded between $188.80 and $352.00.

How much debt does Genmab A/s have?

As of the most recent reporting period, Genmab A/s reported total debt of $5.43B.

How much cash does Genmab A/s have on hand?

Genmab A/s reported $1.72B in cash and cash equivalents in its most recent financial results.

What is Genmab A/s’s dividend yield?

Genmab A/s does not currently have a dividend yield.

Genmab A/s

Genmab A/s Financials at a Glance

GNMSF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Genmab A/s

GNMSF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Genmab A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GNMSF

What is the current price of Genmab A/s?

What is the 52-week range for Genmab A/s?

How much debt does Genmab A/s have?

How much cash does Genmab A/s have on hand?

What is Genmab A/s’s dividend yield?

Premium Investing Services